Please login to the form below

Not currently logged in
Email:
Password:

opioid abuse

This page shows the latest opioid abuse news and features for those working in and with pharma, biotech and healthcare.

Nektar confirms BMS deal for NKTR-214 is on track

Nektar confirms BMS deal for NKTR-214 is on track

Almost forgotten among the interest in Nektar’s immuno-oncology pipeline – which also includes three other candidates in clinical trials – is NKTR-181, a first-in-class, abuse-deterrent opioid analgesic ... The drug promises to deliver pain relief

Latest news

More from news
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin.  . ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.  .

  • How digital content is helping physicians curb the opioid abuse epidemic

    On the other hand are the prescribers who are driven to help their patients but finding that their pain management protocols are now complicated by what the national opioid abuse epidemic ... The pain management topic found under most specialties at

  • Aptus Health

    How digital content is helping physicians curb the opioid abuse epidemic.

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics